Engineering CRISPR/Cas9 therapeutics for cancer precision medicine

The discovery of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated protein 9 (Cas9) technology has revolutionized field of cancer treatment. This review explores usage of CRISPR/Cas9 for editing and investigating genes involved in human carcinogenesis. It provi...

Full description

Bibliographic Details
Published in:	Frontiers in Genetics
Main Authors:	Aditya Kumar Sharma, Anil K. Giri
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Subjects:	CRISPR/Cas9 cancer treatment preclinical studies precision medicine CRISPR/Cas9 therapeutics
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2024.1309175/full

Similar Items

Harnessing the evolving CRISPR/Cas9 for precision oncology
by: Tianye Li, et al.
Published: (2024-08-01)

Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology
by: Andrew C. Brane, et al.
Published: (2019-02-01)

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
by: Fei Zhang, et al.
Published: (2019-06-01)

An overview of applications of CRISPR-Cas technologies in biomedical engineering
by: Saleh Jamehdor, et al.
Published: (2020-10-01)

CRISPR-Cas9: A Powerful Tool to Efficiently Engineer <i>Saccharomyces cerevisiae</i>
by: João Rainha, et al.
Published: (2020-12-01)

CRISPR/Cas9 in Chronic Lymphocytic Leukemia
by: María Hernández-Sánchez
Published: (2022-05-01)

Current Applications and Future Perspectives of CRISPR-Cas9 for the Treatment of Lung Cancer
by: Tiruneh G/Medhin M, et al.
Published: (2021-05-01)

A Review: CRISPR Cas System and the Mechanism With an Inhibition of Binding of CRISPR Cas‐9
by: Akram Hosen, et al.
Published: (2025-01-01)

CRISPR/Cas9 technology in the modeling of and treatment of mucopolysaccharidosis
by: Mehran Reyhani-Ardabili, et al.
Published: (2024-09-01)

RNA-dependent RNA targeting by CRISPR-Cas9
by: Steven C Strutt, et al.
Published: (2018-01-01)

Harnessing bacterial immunity: CRISPR-Cas system as a versatile tool in combating pathogens and revolutionizing medicine
by: Mushtak T. S. Al-Ouqaili, et al.
Published: (2025-05-01)

Precision oncology revolution: CRISPR-Cas9 and PROTAC technologies unleashed
by: Karim Kanbar, et al.
Published: (2024-07-01)

Oncogenic Human Papillomavirus: Application of CRISPR/Cas9 Therapeutic Strategies for Cervical Cancer
by: Shuai Zhen, et al.
Published: (2017-12-01)

Comparison of CRISPR-Cas9, CRISPR-Cas12f1, and CRISPR-Cas3 in eradicating resistance genes KPC-2 and IMP-4
by: Jun Huang, et al.
Published: (2025-06-01)

CRISPR/Cas patents and health-related publications in South America
by: LARIANE FRÂNCIO, et al.
Published: (2023-06-01)

Precisely Targeted Nanoparticles for CRISPR-Cas9 Delivery in Clinical Applications
by: Xinmei Liu, et al.
Published: (2025-04-01)

CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells
by: Julie Brault, et al.
Published: (2023-01-01)

Progress in CRISPR/Cas9 for CAR-T cell therapy of tumors
by: WU Qi, WANG Shaobo
Published: (2023-08-01)

Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells
by: Qiupeng Zheng, et al.
Published: (2014-09-01)

An improved plant CRISPR-Cas9 system for generating Cas9-free multiplex mutants
by: Jun-Li Wang, et al.
Published: (2021-01-01)

Nanotechnology-Based Delivery of CRISPR/Cas9 for Cancer Treatment: A Comprehensive Review
by: Mohd Ahmar Rauf, et al.
Published: (2025-07-01)

Harnessing an anti-CRISPR protein for powering CRISPR/Cas9-mediated genome editing in undomesticated Bacillus strains
by: Man Su Kim, et al.
Published: (2025-06-01)

Expanding application of CRISPR-Cas9 system in microorganisms
by: Jing Zhao, et al.
Published: (2020-12-01)

CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review
by: Emir Begagić, et al.
Published: (2024-01-01)

CRISPR/Cas9 system and its applications in nervous system diseases
by: Haibin Jiang, et al.
Published: (2024-03-01)

Therapeutic Applications of the CRISPR-Cas System
by: Kyungmin Kang, et al.
Published: (2022-09-01)

Advancements in CRISPR/Cas systems for disease treatment
by: Yangsong Xu, et al.
Published: (2025-06-01)

CRISPR/Cas in dermatology: A scoping review of candidate diseases for clinical applications
by: Jonathan C. Hwang, BS, et al.
Published: (2025-09-01)

CRISPR Cas systems: From bacterial defense mechanisms to revolutionary tools reshaping genetic research and translation therapeutics
by: Kamran Saeed, et al.
Published: (2025-06-01)

Disease modeling and stem cell immunoengineering in regenerative medicine using CRISPR/Cas9 systems
by: Ainsley Mike Antao, et al.
Published: (2020-01-01)

A transient CRISPR/Cas9 expression system for genome editing in Trypanosoma brucei
by: Sebastian Shaw, et al.
Published: (2020-06-01)

Identification of the EH CRISPR‐Cas9 system on a metagenome and its application to genome engineering
by: Belen Esquerra‐Ruvira, et al.
Published: (2023-07-01)

Fundamental CRISPR-Cas9 tools and current applications in microbial systems
by: Pingfang Tian, et al.
Published: (2017-09-01)

Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
by: Bashdar Mahmud Hussen, et al.
Published: (2023-07-01)

Targeted intracellular delivery of Cas13 and Cas9 nucleases using bacterial toxin-based platforms
by: Songhai Tian, et al.
Published: (2022-03-01)

Removal of extra sequences with I-SceI in combination with CRISPR/Cas9 technique for precise gene editing in Drosophila
by: Nikolay Zolotarev, et al.
Published: (2019-04-01)

CRISPR/Cas9-Based therapeutics as a promising strategy for management of Alzheimer’s disease: progress and prospects
by: Mohamad Sultan Khan, et al.
Published: (2025-04-01)

CRISPR/Cas9 for hepatitis B virus infection treatment
by: Bo Cai, et al.
Published: (2023-05-01)

CRISPR/Cas9-mediated genome editing in nonhuman primates
by: Yu Kang, et al.
Published: (2019-10-01)

CRISPR/Cas9: the Jedi against the dark empire of diseases
by: Sehrish Khan, et al.
Published: (2018-03-01)